Multi-stakeholder group launches value assessment tool

The Innovation and Value Initiative has launched its Open-Source Value Project, which seeks to bring greater transparency to the estimation of new therapeutics' value via an interactive online platform. The tool incorporates published data from randomized controlled trials, as well as published real-world evidence studies on treatment outcomes, to estimate treatment cost and cost-effectiveness of new drugs.

The first model launched is for rheumatoid arthritis. It allows users to select specific sequences of treatment regimens and patient population demographics, including age, gender distribution and whether the population is treatment-naïve. ...